However, given the importance of this process in the inactivation of RKIP, it is very likely that this role will be investigated soon as done in multiple myeloma (MM), a plasma-cell neoplastic disorder arising from a premalignant disease known as monoclonal gammopathy of undetermined significance (MGUS). This evidence concerns the gene PEBP1 and plasma cell myeloma.